CPDC Announces Closure of Phase 3 Clinical Trial of [18F]PSMA-1007 Prostate Cancer Diagnostic Imaging Agent

Significant Milestone on the Path to Submission for Canadian Regulatory Approval in Late 2024 HAMILTON, ON, March 13, 2024 – The Centre for Probe Development and Commercialization (CPDC), a global leader in the development and commercialization of radiopharmaceuticals, today announced the closure of the Canadian Phase 3 trial for [18F]PSMA-1007. [18F]PSMA-1007 is a positron-emitting tomography … Read more

CPDC Celebrates Founder John Valliant and His Sixteen-Year Commitment to CPDC

HAMILTON, ON, July 29, 2024 – The Centre for Probe Development and Commercialization (CPDC), a global leader in radiopharmaceutical development and commercialization, today announced that its Founder, John Valliant, Ph.D., has stepped down from its Board of Directors. Dr. Valliant established CPDC in 2008 as a Centre of Excellence for the Commercialization of Research in … Read more

CPDC Funds Research at CAMH for Developing Alk2-Targeting Pet Tracer for Diagnosis of Pediatric Brain Cancer

HAMILTON, ON and TORONTO, ON, July 6, 2023 – The Centre for Probe Development and Commercialization (CPDC) is pleased to announce a collaboration with Dr. Neil Vasdev at the Centre for Addiction and Mental Health (CAMH) to develop a novel positron emission tomography (PET) tracer specific for the activin receptor-like kinase 2 (ALK2) protein. Under … Read more

CPDC Funds Research at Simon Fraser University for Developing an LAT1-Targeting PET Tracer for Imaging Cancer

HAMILTON, ON and VANCOUVER, BC, July 4, 2023 – The Centre for Probe Development and Commercialization (CPDC) is proud to announce its funding of a new research project led by Dr. Robert Britton at Simon Fraser University (SFU) aimed at developing a novel positron emission tomography (PET) tracer that targets the L-type amino acid transporter … Read more

The Centre For Probe Development And Commercialization and Triumf Innovations to Receive Up To $35 Million in Funding for their Canadian Medical Isotope Ecosystem

The Canadian Medical Isotope Ecosystem will support the development, production, advancement and distribution of isotopes, and position Canada as an international medical isotope powerhouse VANCOUVER, BC, and HAMILTON, ON, June 27, 2023 — The Centre for Probe Development and Commercialization (CPDC) and TRIUMF Innovations today announced they will receive up to $35 million in funding for … Read more